Results 131 to 140 of about 78,921 (263)
Cancer Medicine, Volume 15, Issue 9, September 2026.ABSTRACT Background T‐cell–engaging bispecific antibodies are increasingly utilised in haematological malignancies and are beginning to be adopted in solid‐tumour treatment protocols. Cytokine release syndrome and neurotoxicity are well recognised, but target‐specific dermatological adverse event reporting patterns remain poorly defined.
Saikat Mandal +2 more
wiley +1 more source
, 2012 Jaideep DograPoly Clinic, Central Government Health Scheme, Jaipur, Rajasthan, IndiaPurpose: Two mega trials have raised the question as to whether the hypothesis that infection plays a role in atherosclerosis is still relevant.
Dogra J
core
Clinical Case Reports, Volume 14, Issue 9, September 2026.ABSTRACT Stevens‐Johnson syndrome/toxic epidermal necrolysis (SJS/TEN) overlap is a rare, life‐threatening mucocutaneous reaction typically induced by medications. Reports from Central America remain scarce. We present two contrasting cases of SJS/TEN overlap from Nicaragua.
Marvin Alfaro +2 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 9, September 2026.ABSTRACT An 82‐year‐old woman with JAK2‐mutated myelofibrosis who developed hemoptysis after initiation of ruxolitinib. She presented with anemia and ground‐glass opacities and was treated with antibiotics. She was readmitted with worsening respiratory symptoms. Sputum cultures yielded Mycobacterium avium.
Mataichi Sekiya +3 more
wiley +1 more source
Clinical Case Reports, Volume 14, Issue 9, September 2026.ABSTRACT A Type 1 Brugada ECG pattern may mimic acute coronary syndrome. Careful assessment of cardiac biomarkers, electrolyte abnormalities, medications, and possible substance exposure is essential. Without follow‐up ECG, provocative testing, or genetic evaluation, the finding should be described cautiously as a Brugada‐pattern ECG rather than ...
Ghadeer Doman
wiley +1 more source
The Journal of Clinical Pharmacology, Volume 66, Issue 9, September 2026.Abstract Accurate drug concentration measurement is essential for precision pharmacotherapy, but conventional therapeutic drug monitoring (TDM) requires venous sampling, increasing patient burden, and potentially limiting participation in TDM and model‐informed precision dosing (MIPD).
Hari Prabhath Tummala +5 more
wiley +1 more source
Heterogeneity of azithromycin resistance markers in <i>Neisseria gonorrhoeae</i> and challenges in implementing molecular assays for routine surveillance. [PDF]
New Microbes New InfectYuan Q, Xiu L, Peng J.
europepmc +1 more source
Journal of Periodontology, Volume 97, Issue 9, Page 1871-1884, September 2026.Abstract Background This randomized controlled trial aims to evaluate alveolar ridge preservation (ARP) with or without a biologically active amnion–chorion membrane (BACM). Methods Thirty patients requiring tooth extraction in the esthetic zone were randomly assigned to 2 groups.
Magdalena Orlowska +8 more
wiley +1 more source
Determining intracellular and extracellular activities of azithromycin against azithromycin-resistant Salmonella Typhi and their association with clinical treatment responses. [PDF]
EBioMedicineThuy NNP +15 more
europepmc +1 more source
Otolaryngology–Head and Neck Surgery, Volume 175, Issue 3, Page 556-570, September 2026.Abstract Objective Chronic rhinosinusitis (CRS) affects all sociodemographic groups. While studies have explored social determinants of health (SDOH), sociodemographics, and health behaviors, their specific effects on CRS outcomes are unclear, making tailored care difficult.
Kassandra M. Jade +8 more
wiley +1 more source